FDA Regulatory Expertise

Navigate U.S. Market Entry with Confidence

Comprehensive FDA regulatory support for foreign pharmaceutical manufacturers entering the U.S. market. From
ANDA submissions to post-approval compliance.

Request Regulatory Consultation
Learn About Our Expertise

ANDA Pathway Guidance

Complete support for Abbreviated New Drug Application submissions to the FDA.
  • ANDA strategy development and planning
  • Complete application preparation and review
  • FDA correspondence and deficiency response
  • Pre-submission feasibility assessment

Regulatory Dossier Preparation

Expert compilation of regulatory documentation meeting FDA standards.
  • CTD/eCTD format preparation
  • Chemistry, Manufacturing, and Controls(CMC) documentation
  • Bioequivalence study documentation
  • Quality assurance and regulatory compliance review

U.S. Market Entry Strategy

Strategic planning for successful entry into FDA-regulated markets.
  • Competitive landscape analysis
  • Regulatory pathway selection
  • Timeline and resource planning
  • Risk assessment and mitigation strategies

Post-Approval Compliance

Ongoing regulatory support to maintain FDA compliance after approval.
  • Annual report preparation and submission
  • Change control and supplement management
  • FDA inspection readiness support
  • Adverse event reporting and pharmacovigilance

Initial Assessment

Evaluate product viability and regulatory pathway

Strategy Development

Create comprehensive regulatory roadmap

Dossier Preparation

Compile and review all regulatory documentation

FDA Submission

Submit application and manage FDA correspondence

Ongoing Support

Post-approval compliance and maintenance

Why Choose UPPharmaceutical

Partner with regulatory experts who understand both pharmaceutical science and FDA requirements.

Proven Track Record

Years of experience successfully guiding pharmaceutical manufacturers through FDA approval processes.

Expert Team

Pharmacists, regulatory affairs specialists, and former FDA reviewers on our team.

High Success Rate

Demonstrated success in ANDA approvals and regulatory submissions across therapeutic categories.